Cipher Pharmaceuticals Inc. (CPHRF)

Cipher Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	39.62	28.84	20.55	9.14	6.35
Cash & Cash Equivalents	39.62	28.84	20.55	9.14	6.35
Cash Growth	37.40%	40.33%	124.76%	44.06%	-38.73%
Receivables	5.06	6.8	6.66	9.22	8.88
Inventory	2.97	2.15	1.65	0.89	1.04
Other Current Assets	0.38	0.37	0.47	0.88	0.96
Total Current Assets	48.03	38.16	29.33	20.13	17.23
Property, Plant & Equipment	0.4	0.48	0.5	1.91	2.2
Long-Term Investments	-1.84	18.94	19.85	21.79	28.28
Goodwill	15.63	15.71	15.71	15.71	15.71
Intangible Assets	1.76	2.75	3.65	4.18	10.38
Other Long-Term Assets	21.54	-2.27	-17.38	-19.44	-27.34
Total Long-Term Assets	37.56	35.62	22.32	24.15	29.23
Total Assets	85.59	73.78	51.65	44.28	46.46
Accounts Payable	4.62	4.11	5.56	6.83	7.61
Deferred Revenue	0.52	0.26	0.45	0.31	0.27
Current Debt	0.09	0.1	0.06	0.14	7.75
Other Current Liabilities	0	4.9	6.23	2.65	0.99
Total Current Liabilities	5.23	9.37	12.29	9.92	16.62
Long-Term Debt	0.26	0.33	0.46	1.71	1.82
Other Long-Term Liabilities	-0	0	0	0.01	0.01
Total Long-Term Liabilities	0.26	0.33	0.46	1.72	1.83
Total Liabilities	5.48	9.7	12.75	11.63	18.44
Total Debt	0.35	0.43	0.52	1.85	9.57
Debt Growth	-17.95%	-17.05%	-72.09%	-80.68%	-45.54%
Common Stock	17.92	17.72	18.12	18.7	18.68
Retained Earnings	65.93	50.52	25.2	18.4	13.87
Comprehensive Income	-9.47	-9.51	-9.51	-9.51	-9.51
Shareholders' Equity	80.11	64.08	38.9	32.64	28.01
Total Liabilities and Equity	85.59	73.78	51.65	44.28	46.46
Net Cash / Debt	39.27	28.41	20.03	7.29	-3.22
Net Cash / Debt Growth	38.24%	41.81%	174.67%	-	-
Net Cash Per Share	1.54	1.10	0.75	0.27	-0.12
Working Capital	42.8	28.79	17.03	10.21	0.62
Book Value Per Share	3.20	2.53	1.46	1.21	1.04

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.